A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in human cells,

Researchers have shown they can eradicate advanced-stage mesothelioma tumors with a treatment using cytokine “drug factory” implants.

The most aggressive triple negative breast cancer affects 1,000 patients per year in Belgium, while the figure worldwide is 225,000.

An AI-based home screening test to detect oral and throat cancers from saliva samples is now available in the United States .

By treating patients with a combination of two chemotherapy drugs, they were able to re-sensitize the cancer cells to ICB treatment.

A vaccine using patients’ immune cells to target brain cancer can extend survival by many months or, in some cases, years according to study

Understanding the molecular mechanisms of metastasis is therefore a key piece of the puzzle in the fight against cancer.

The key to these vaccines appears to be neoantigens in the pancreatic tumors, which alert the immune system to keep the cancer at bay.

Researchers have tested the possibility of artificially maturing breast cancer cells as an approach to turn them into a more normal cell.

Albert Einstein College of Medicine research team used different human immune cells known as natural killer (NK) cells with dramatic results

Doctors in the UK hope that thousands of men with prostate cancer could be cured through an innovative hour-long operation.

T cells snuggle up to targeted diseased cells and form an intimate junction between the two, called the ‘cytotoxic immunological synapse’.

The work also shows how a new technique—single-cell analysis—can detect tumours at very early stages, or a predisposition to developing them

New research about how cancer-related proteins bind the metal and how they interact with other proteins, opens up potential new drug targets

In every case, the cancer disappeared after immunotherapy — without the need for the standard treatments of radiation, surgery, or chemo.

Scientists investigating the mechanics of the early stages of lung cancer have identified a new potential treatment aiding early detection.

A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed.

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor.

The European honeybee (Apis mellifera) has been the source of a number of products used medicinally by humans, such as honey and venom.

A team of Canadian researchers from Université de Montréal has designed and validated a new class of drug transporters made of DNA.